Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 14176 - 14200 of 14583 in total
BMS-903452 has been used in trials studying the treatment of Diabetes.
Investigational
Dapaconazole has been used in trials studying the treatment of Tinea Pedis.
Investigational
Dalcetrapib is under investigation for the treatment of Acute Coronary Syndrome.
Investigational
LY2886721 has been used in trials studying the basic science of Alzheimer's Disease.
Investigational
Azeliragon has been used in trials studying the treatment of Alzheimer's Disease.
Investigational
Ritanserin has been used in trials studying the treatment of Cocaine-Related Disorders.
Investigational
E6005 has been used in trials studying the treatment of Atopic Dermatitis.
Investigational
Get 73 has been investigated for the treatment of Alcohol Dependence.
Investigational
TBD has been used in trials studying the treatment of Adenocarcinoma.
Investigational
Experimental
Experimental
Experimental
Experimental
Experimental
Experimental
Experimental
Experimental
Experimental
Experimental
Experimental
Experimental
Imiglitazar has been used in trials studying the treatment of Diabetes Mellitus.
Investigational
MRX-I has been used in trials studying the treatment of Bacterial Infections.
Investigational
XMT-1001 is a polymer-based prodrug of camptothecin (CPT), a well-characterized topoisomerase I inhibitor with potent anti-tumor activity. It is a water-soluble macromolecular conjugate of camptothecin (CPT). In this novel CPT pro-drug, CPT is conjugated with a 70 kDa biodegradable hydrophilic polyacetal, poly (1-hydroxymethylene hydroxylmethylformal). XMT-1001 has demonstrated an improved therapeutic...
Investigational
Matched Description: … XMT-1001 has demonstrated an improved therapeutic window as compared with CPT and irinotecan in human …
Displaying drugs 14176 - 14200 of 14583 in total